Cel Sci CVM
NYSE CVM
$1.42 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cel Sci (CVM) Amortizatization of Intangibles (2017 - 2018)

Cel Sci (CVM) posted Amortizatization of Intangibles of $933340.0 for Q2 2018, up 126.89% sequentially from $411367.0 in Q1 2018, and up 4253.06% YoY from $21441.0 in Q2 2017.

Cel Sci (CVM) Amortizatization of Intangibles (2017 - 2018) Analysis & Trends

Cel Sci has reported Amortizatization of Intangibles for 2 years, with the latest figure at $933340.0 in Q2 2018.

  • Quarterly Amortizatization of Intangibles rose 4253.06% year-over-year to $933340.0 in Q2 2018, while the trailing twelve-month figure through Mar 2019 was $933340.0 (down 51.91% YoY) and the FY2018 annual result came in at $2.0 million, up 113.19% from the prior year.
  • Amortizatization of Intangibles climbed to $933340.0 in Q2 2018 per CVM's latest filing, from $411367.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $933340.0 in Q2 2018 and troughed at $21441.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cel Sci 2.12 Mn -4.42 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 933,340.00
Jun 30, 2018 933,340.00
Mar 31, 2018 411,367.00
Mar 31, 2018 411,367.00
Dec 31, 2017 611,717.00
Dec 31, 2017 611,717.00
Sep 30, 2017 896,251.00
Sep 30, 2017 896,251.00
Jun 30, 2017 21,441.00
Jun 30, 2017 21,441.00